Dr. Serhat Gumrukcu, is the founder and executive director of Seraph Research Institute and co- founder and inventor of Enochian BioSciences. In this CBSN interview, CEO of Enochian BioSciences, Mark Dybul, discusses the prediction of vaccine-resistant strains of COVID-19 developing in the future with CBSN’s “Red […]
Recent Features
Yahoo! Life ran an article that featured COVID prevention recommendations from Seraph Research Institute founder, Dr. Serhat Gumrukcu. The article titled, 6 Safest Things to do Right Now, During Omicron, reached over 3.6 billion readers.
Infectious disease expert and pioneering scientific researcher, Seraph Research Institute founder, Dr. Serhat Gumrukcu, was quoted in a recent MarketWatch article titled, “Doctors reveal the best face masks to protect kids from the omicron coronavirus variant.” In the article Dr. […]
Listen to Fancy Labcoat Guild hosts Guy Rohkin and Ali Dashti interview Dr. Gumrukcu in an eposide titled “Science is an art–not an equation with Dr. Serhat Gumrukcu.”The Fancy Labcoat guild is a space where scientists share their insights about […]
When the health writers at Eat This, Not That! wanted infectious disease experts to comment on The #1 Worst Place You Could Go Right Now, Say Virus Experts, they started with Seraph Research founder, Dr. Serhat Gumrukcu. In the article, […]
When the health writers at Eat This, Not That! wanted to get some opinions about the future of the COVID pandemic, they reached out to Dr. Gumrukcu and other infectious disease experts for their insights. In the article, Virus Expert […]
Beating COVID Will Require a 5-Part Strategy—Including Mandatory Boosters and a Drug We Don’t Have Yet, appeared in Fortune. The commentary piece was written by Mark Dybul, CEO of Enochian BioSciences and Dr. Serhat Gumrukcu, founder and executive director of […]
When the health writers at Best Life wanted to know what signs to look for to avoid contracting COVID-19 when dining out, they turned to infectious disease expert and research scientist, Dr. Serhat Gumrucku, for comment.
Associated Press (AP), MarketWatch, Yahoo Finance, Globe & Mail and over 120 other media outlets published a press release about Dr. Gumrukcu’s pioneering HIV cell therapy approach successfully completing the FDA Pre-investigational new drug (Pre-IND) stage, bringing the treatment another critical step closer to offering […]
Associated Press (AP), MarketWatch, The New York Times, CNBC and over 115 other media outlets published a press release about Dr. Serhat’s pioneering HIV cell therapy approach – which which moves Seraph Research Institute one step closer to finding a cure […]
12
Page 1 of 2